A myostatin-CCL20–CCR6 axis regulates Th17 cell recruitment to inflamed joints in experimental arthritis

Abstract The interactions of fibroblast-like synoviocyte (FLS)-derived pro-inflammatory cytokines/chemokines and immune cells support the recruitment and activation of inflammatory cells in RA. Here, we show for the first time that the classical myokine myostatin (GDF-8) is involved in the recruitme...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Michelle Fennen, Toni Weinhage, Vanessa Kracke, Johanna Intemann, Georg Varga, Corinna Wehmeyer, Dirk Foell, Adelheid Korb-Pap, Thomas Pap, Berno Dankbar
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/0e68a05c59a446c9abd58a77cfaf8633
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0e68a05c59a446c9abd58a77cfaf8633
record_format dspace
spelling oai:doaj.org-article:0e68a05c59a446c9abd58a77cfaf86332021-12-02T16:15:06ZA myostatin-CCL20–CCR6 axis regulates Th17 cell recruitment to inflamed joints in experimental arthritis10.1038/s41598-021-93599-62045-2322https://doaj.org/article/0e68a05c59a446c9abd58a77cfaf86332021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-93599-6https://doaj.org/toc/2045-2322Abstract The interactions of fibroblast-like synoviocyte (FLS)-derived pro-inflammatory cytokines/chemokines and immune cells support the recruitment and activation of inflammatory cells in RA. Here, we show for the first time that the classical myokine myostatin (GDF-8) is involved in the recruitment of Th17 cells to inflammatory sites thereby regulating joint inflammation in a mouse model of TNFalpha-mediated chronic arthritis. Mechanistically, myostatin-deficiency leads to decreased levels of the chemokine CCL20 which is associated with less infiltration of Th17 cells into the inflamed joints. In vitro, myostatin alone or in combination with IL-17A enhances the secretion of CCL20 by FLS whereas myostatin-deficiency reduces CCL20 secretion, associated with an altered transmigration of Th17 cells. Thus, the communication between activated FLS and Th17 cells through myostatin and IL-17A may likely contribute to a vicious cycle of inflammation, accounting for the persistence of joint inflammation in chronic arthritis. Blockade of the CCL20–CCR6 axis by inhibition of myostatin may, therefore, be a promising treatment option for chronic inflammatory diseases such as arthritis.Michelle FennenToni WeinhageVanessa KrackeJohanna IntemannGeorg VargaCorinna WehmeyerDirk FoellAdelheid Korb-PapThomas PapBerno DankbarNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Michelle Fennen
Toni Weinhage
Vanessa Kracke
Johanna Intemann
Georg Varga
Corinna Wehmeyer
Dirk Foell
Adelheid Korb-Pap
Thomas Pap
Berno Dankbar
A myostatin-CCL20–CCR6 axis regulates Th17 cell recruitment to inflamed joints in experimental arthritis
description Abstract The interactions of fibroblast-like synoviocyte (FLS)-derived pro-inflammatory cytokines/chemokines and immune cells support the recruitment and activation of inflammatory cells in RA. Here, we show for the first time that the classical myokine myostatin (GDF-8) is involved in the recruitment of Th17 cells to inflammatory sites thereby regulating joint inflammation in a mouse model of TNFalpha-mediated chronic arthritis. Mechanistically, myostatin-deficiency leads to decreased levels of the chemokine CCL20 which is associated with less infiltration of Th17 cells into the inflamed joints. In vitro, myostatin alone or in combination with IL-17A enhances the secretion of CCL20 by FLS whereas myostatin-deficiency reduces CCL20 secretion, associated with an altered transmigration of Th17 cells. Thus, the communication between activated FLS and Th17 cells through myostatin and IL-17A may likely contribute to a vicious cycle of inflammation, accounting for the persistence of joint inflammation in chronic arthritis. Blockade of the CCL20–CCR6 axis by inhibition of myostatin may, therefore, be a promising treatment option for chronic inflammatory diseases such as arthritis.
format article
author Michelle Fennen
Toni Weinhage
Vanessa Kracke
Johanna Intemann
Georg Varga
Corinna Wehmeyer
Dirk Foell
Adelheid Korb-Pap
Thomas Pap
Berno Dankbar
author_facet Michelle Fennen
Toni Weinhage
Vanessa Kracke
Johanna Intemann
Georg Varga
Corinna Wehmeyer
Dirk Foell
Adelheid Korb-Pap
Thomas Pap
Berno Dankbar
author_sort Michelle Fennen
title A myostatin-CCL20–CCR6 axis regulates Th17 cell recruitment to inflamed joints in experimental arthritis
title_short A myostatin-CCL20–CCR6 axis regulates Th17 cell recruitment to inflamed joints in experimental arthritis
title_full A myostatin-CCL20–CCR6 axis regulates Th17 cell recruitment to inflamed joints in experimental arthritis
title_fullStr A myostatin-CCL20–CCR6 axis regulates Th17 cell recruitment to inflamed joints in experimental arthritis
title_full_unstemmed A myostatin-CCL20–CCR6 axis regulates Th17 cell recruitment to inflamed joints in experimental arthritis
title_sort myostatin-ccl20–ccr6 axis regulates th17 cell recruitment to inflamed joints in experimental arthritis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/0e68a05c59a446c9abd58a77cfaf8633
work_keys_str_mv AT michellefennen amyostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis
AT toniweinhage amyostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis
AT vanessakracke amyostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis
AT johannaintemann amyostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis
AT georgvarga amyostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis
AT corinnawehmeyer amyostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis
AT dirkfoell amyostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis
AT adelheidkorbpap amyostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis
AT thomaspap amyostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis
AT bernodankbar amyostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis
AT michellefennen myostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis
AT toniweinhage myostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis
AT vanessakracke myostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis
AT johannaintemann myostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis
AT georgvarga myostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis
AT corinnawehmeyer myostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis
AT dirkfoell myostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis
AT adelheidkorbpap myostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis
AT thomaspap myostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis
AT bernodankbar myostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis
_version_ 1718384274967625728